Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and lifestyle intervention for prevention of age-related chronic diseases in metabolic syndrome
2012-005427-32Phase 3Completed
- Sponsor
- Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano
- Start
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metformin in cardiometabolic risk (CMR) (4 arms), sponsored by Fondazione IRCCS - Istituto Nazionale dei Tumori di Milano. Primary endpoint: Total incidence of age-related chronic diseases. Started Jul 2013; status: completed.
02
Drugs
metformin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on 2012-005427-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005427-32.